Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
暂无分享,去创建一个
M. Cronin | S. Paik | G. Tang | S. Shak | Chungyeul Kim | J. Baker | W. Kim | F. Baehner | D. Watson | J. Bryant | J. Costantino | C. Geyer | D. Wickerham | N. Wolmark
[1] R. Rubens,et al. Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.
[2] R. Simon,et al. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. , 1978, The New England journal of medicine.
[3] R. W. Baldwin,et al. Tumour aneuploidy, prognostic parameters and survival in primary breast cancer. , 1987, British Journal of Cancer.
[4] R. Camplejohn,et al. Histological grade, elastosis, DNA ploidy and the response to chemotherapy of breast cancer. , 1987, British Journal of Cancer.
[5] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[6] Robert Gray,et al. Flexible Methods for Analyzing Survival Data Using Splines, with Applications to Breast Cancer Prognosis , 1992 .
[7] T. Aas,et al. Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome. , 1996, Acta oncologica.
[8] B Fisher,et al. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. , 1997, Journal of the National Cancer Institute.
[9] K. Franssila,et al. A multivariate analysis of tumour biological factors predicting response to cytotoxic treatment in advanced breast cancer. , 1998, British Journal of Cancer.
[10] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[11] S. Martino,et al. Prediction of Node-Negative Breast Cancer Outcome by Histologic Grading and S-Phase Analysis by Flow Cytometry: An Eastern Cooperative Oncology Group Study (2192) , 2001, American journal of clinical oncology.
[12] S. Edge,et al. NCCN: Breast cancer. , 2001, Cancer control : journal of the Moffitt Cancer Center.
[13] Robert J. Mayer,et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. , 2001, Journal of the National Cancer Institute.
[14] R. Bast,et al. 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] J. Stec,et al. Global Gene Expression Changes During Neoadjuvant Chemotherapy for Human Breast Cancer , 2002, Cancer journal.
[16] E. Feuer,et al. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. , 2002, Journal of the National Cancer Institute.
[17] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[18] Norman Wolmark,et al. Multi-gene Rt-pcr assay for predicting recurrence in node negative breast cancer patients-nsabp studies B-20 and B-14 , 2003 .
[19] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] C. Cordon-Cardo,et al. A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.
[21] R. Salunga,et al. Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] Syed Mohsin,et al. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer , 2003, The Lancet.
[23] R. Gelber,et al. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] M. Cronin,et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.
[25] A. Luini,et al. Chemotherapy Is More Effective in Patients with Breast Cancer Not Expressing Steroid Hormone Receptors , 2004, Clinical Cancer Research.
[26] J. Stec,et al. Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Debjani Dutta,et al. Measurement of gene expression in archival paraffin-embedded tissues: development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay. , 2004, The American journal of pathology.
[28] J. Bryant,et al. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials , 2004, The Lancet.
[29] I. Henderson,et al. The relationship between prognostic and predictive factors in the management of breast cancer , 2004, Breast Cancer Research and Treatment.
[30] Daniel F. Hayes,et al. Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful? , 2004, Breast Cancer Research and Treatment.
[31] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[32] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[33] Program for the Assessment of Clinical Cancer Tests (PACCT): implementing promising assays into clinical practice , 2005, Expert review of molecular diagnostics.
[34] Roman Rouzier,et al. Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.